ea0041ep605 | Endocrine tumours and neoplasia | ECE2016
Rinke Anja
, Muller Lothar
, Maintz Christoph
, Bolling Claus
, Raderer Markus
, Christ-Crain Mirjam
, Hoffmanns Philipp
, Chevts Vitali
, Houchard Aude
, Petersenn Stephan
Introduction: This non-interventional study assesses real-life use and potential predictive parameters for lanreotide (LAN) in pts with either acromegaly (ACRO) or NET over a period of 24 months. We present a pre-specified interim analysis after first 6 months of therapy.Methods: The primary objective is to evaluate the long term treatment response under LAN and to correlate it with early changes of biochemical markers. The planned sample size is 152 (76...